This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université Paris-Saclay. Active years: 2023.
Company Filing History:
1 out of 5,383 
1 out of 98 
Years Active: 2023
Title: Romain Canioni: Innovator in Nanoparticulate Prodrugs
Introduction
Romain Canioni is a notable inventor based in Versailles, France. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of anti-inflammatory drug formulations. His innovative work focuses on corticosteroid prodrug nanoparticles, which have the potential to enhance therapeutic efficacy.
Latest Patents
Romain Canioni holds a patent for "Nanoparticulate prodrugs." This invention relates to a novel anti-inflammatory drug formulation that includes a nanoparticle comprising a therapeutic agent and a surface coating material. The patent also details a process for manufacturing these nanoparticles, along with pharmaceutical compositions and kits that utilize this technology. He has 1 patent to his name.
Career Highlights
Throughout his career, Romain Canioni has been associated with prestigious institutions such as Université Paris-Saclay and the Centre National De La Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Romain has collaborated with notable colleagues, including Nicolas Tsapis and Mathilde Lorscheider. These partnerships have enriched his research and fostered innovation in the field of drug formulation.
Conclusion
Romain Canioni's contributions to the development of nanoparticulate prodrugs represent a significant advancement in pharmaceutical science. His innovative approach to drug formulation has the potential to improve therapeutic outcomes for patients.